Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...
Versus the start of this year, Cingulate stock is now up nearly 140%. The pending Trimodal patent is a key component of ...
Stocktwits on MSN
Cingulate stock jumps overnight: US Patent Office clears ADHD drug filing ahead of May FDA catalyst
The USPTO cleared a patent filed in November 2023, with a status indicating it has been approved and the patent is expected ...
15d
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing
This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.
XDA Developers on MSN
8 local LLM settings most people never touch that fixed my worst AI problems
If you run LLMs locally, these are the settings you need to be aware of.
The technology industry is obsessed with the future. satellites smartphones A.I. chips smart glasses smartphones satellites smart glasses A.I. chips Many of our modern marvels are rooted in the legacy ...
The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic ...
Canada’s inflation rate slowed to 1.8 per cent in February, down from 2.3 per cent in January, as the end of the GST/HST ...
WebFX reports analyze 237,000 home service queries, revealing AI Overviews impact search visibility and strategy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results